Company: ACBM
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001640334-25-001486
Chunk: 0

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 14, 2025, Pao-Chi Chu resigned as director, chairman and chief executive officer of the Company, effective upon the appointment of a successor. Mr. Chu's resignation did not result from any disagreement with the Company.

On August 14, 2025, the Company's board of directors appointed Yu-Ting, Su as a director and as the Company's chairman and chief executive officer, effective on August 14, 2025. Ms. Su was vice president, cell banking division of BioSpring Co., Ltd., a nucleic acid manufacturing and analysis company, from January 2023 until August 2025. From August 2020 until December 2022, she was vice president, new drug development division of BioSeed Co., Ltd., an agriculture biotechnology company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: August 14.2025      ACRO BIOMEDICAL CO., LTD.                       
                            By:                            /s/ Yu-Ting, Su  
                                                           Yu-Ting, Su      

   3